

A practical guide for dermatologists and prescribers to help patients find Claravis (Isotretinoin) during supply disruptions — 5 actionable steps.
You prescribed Isotretinoin because your patient's acne warrants it. Now they're calling your office because the pharmacy can't fill it. This scenario has become increasingly common as generic Isotretinoin supply remains uneven across the country.
As a prescriber, you're in a unique position to help patients navigate these supply challenges. This guide provides a practical workflow for ensuring your patients can find Claravis — or an equivalent Isotretinoin brand — and stay on therapy.
Generic Isotretinoin (Claravis, Amnesteem, Myorisan, Zenatane) has experienced intermittent supply disruptions since 2022. As of 2026:
For a full timeline and analysis, see our provider shortage briefing.
Understanding the bottlenecks helps you guide patients more effectively:
Prescribe "Isotretinoin" rather than a specific brand name. This allows the pharmacy to dispense whichever generic is in stock — Claravis, Amnesteem, Myorisan, or Zenatane. Ensure "substitution permitted" is indicated on the prescription.
If a patient has commercial insurance and supply is consistently problematic, consider prescribing Absorica with the manufacturer savings card, which can reduce copays to as low as $10/month.
When a specific strength is unavailable, alternative dosing can maintain treatment continuity:
Document the rationale for any dose modifications and counsel patients to take the medication with a fatty meal regardless of strength.
Medfinder provides real-time pharmacy stock searches for Isotretinoin. You can:
This single step can eliminate the frustrating cycle of patients calling multiple pharmacies and then calling your office when they can't find it.
Identify two to three pharmacies in your area that reliably stock Isotretinoin:
At the start of therapy, set expectations about potential supply challenges:
In rare cases where no Isotretinoin brand can be sourced within a clinically acceptable timeframe, consider bridging strategies:
These are not equivalent substitutes for Isotretinoin in severe nodular acne but can help maintain some disease control during unavoidable treatment gaps. Plan to resume Isotretinoin as soon as supply is available and adjust the cumulative dose target accordingly.
Integrating these steps into your standard Isotretinoin workflow:
Supply disruptions for Isotretinoin are frustrating for patients and providers alike, but they're manageable with proactive planning. By writing flexible prescriptions, leveraging real-time stock tools like Medfinder, and educating patients upfront, you can significantly reduce treatment gaps and improve outcomes.
For the clinical and supply background, see our Claravis shortage briefing for providers. For cost reduction strategies, see how to help patients save money on Claravis.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.